Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Rodent models for investigating the dysregulation of immune responses in type 1 diabetes.

Chou FC, Chen HY, Chen SJ, Fang MC, Sytwu HK.

J Diabetes Res. 2013;2013:138412. doi: 10.1155/2013/138412. Epub 2013 Mar 11.

2.

Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.

You S, Chatenoud L.

Methods Mol Biol. 2016;1371:117-42. doi: 10.1007/978-1-4939-3139-2_8.

PMID:
26530798
3.

Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice.

Kachapati K, Bednar KJ, Adams DE, Wu Y, Mittler RS, Jordan MB, Hinerman JM, Herr AB, Ridgway WM.

J Autoimmun. 2013 Dec;47:94-103. doi: 10.1016/j.jaut.2013.09.002. Epub 2013 Oct 18.

PMID:
24145149
4.
5.

Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.

Jeon K, Lim H, Kim JH, Thuan NV, Park SH, Lim YM, Choi HY, Lee ER, Kim JH, Lee MS, Cho SG.

Stem Cells Dev. 2012 Sep 20;21(14):2642-55. doi: 10.1089/scd.2011.0665. Epub 2012 Jun 1.

6.

CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease.

Yang GX, Wu Y, Tsukamoto H, Leung PS, Lian ZX, Rainbow DB, Hunter KM, Morris GA, Lyons PA, Peterson LB, Wicker LS, Gershwin ME, Ridgway WM.

J Immunol. 2011 Jan 15;186(2):1259-67. doi: 10.4049/jimmunol.1001597. Epub 2010 Dec 17.

7.

Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.

Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.

Ann N Y Acad Sci. 2005 Jun;1051:72-87. Review.

PMID:
16126946
8.

Foxp3(+) regulatory T cells in mouse models of type 1 diabetes.

Petzold C, Riewaldt J, Watts D, Sparwasser T, Schallenberg S, Kretschmer K.

J Diabetes Res. 2013;2013:940710. doi: 10.1155/2013/940710. Epub 2013 Mar 14.

9.

Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.

Ivakine EA, Fox CJ, Paterson AD, Mortin-Toth SM, Canty A, Walton DS, Aleksa K, Ito S, Danska JS.

J Immunol. 2005 Jun 1;174(11):7129-40.

10.

Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.

Shultz LD, Pearson T, King M, Giassi L, Carney L, Gott B, Lyons B, Rossini AA, Greiner DL.

Ann N Y Acad Sci. 2007 Apr;1103:77-89. Epub 2007 Mar 1.

PMID:
17332083
11.

Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse.

Giarratana N, Penna G, Adorini L.

Methods Mol Biol. 2007;380:285-311. Review.

PMID:
17876100
12.

Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.

Mojibian M, Lam AW, Fujita Y, Asadi A, Grassl GA, Dickie P, Tan R, Cheung AT, Kieffer TJ.

Gastroenterology. 2014 Jul;147(1):162-171.e6. doi: 10.1053/j.gastro.2014.03.020. Epub 2014 Mar 21.

PMID:
24662331
13.

Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.

Zhao Y, Guo C, Hwang D, Lin B, Dingeldein M, Mihailescu D, Sam S, Sidhwani S, Zhang Y, Jain S, Skidgel RA, Prabhakar BS, Mazzone T, Holterman MJ.

Biochem Biophys Res Commun. 2010 Sep 3;399(4):629-36. doi: 10.1016/j.bbrc.2010.07.128. Epub 2010 Aug 4.

PMID:
20691153
14.

Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.

Serreze DV, Niens M, Kulik J, Dilorenzo TP.

Methods Mol Biol. 2010;602:119-34. doi: 10.1007/978-1-60761-058-8_8.

PMID:
20012396
15.

Exposure to DDT metabolite p,p'-DDE increases autoimmune type 1 diabetes incidence in NOD mouse model.

Cetkovic-Cvrlje M, Olson M, Schindler B, Gong HK.

J Immunotoxicol. 2016;13(1):108-18. doi: 10.3109/1547691X.2015.1017060. Epub 2015 Feb 27.

PMID:
25721050
16.

Use of nonobese diabetic mice to understand human type 1 diabetes.

Thayer TC, Wilson SB, Mathews CE.

Endocrinol Metab Clin North Am. 2010 Sep;39(3):541-61. doi: 10.1016/j.ecl.2010.05.001. Epub 2010 Jul 8. Review.

17.

Viral infections as potential triggers of type 1 diabetes.

van der Werf N, Kroese FG, Rozing J, Hillebrands JL.

Diabetes Metab Res Rev. 2007 Mar;23(3):169-83. Review.

PMID:
17103489
18.

Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS.

J Virol. 2002 Dec;76(23):12097-111.

19.

IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.

Diaz-de-Durana Y, Lau J, Knee D, Filippi C, Londei M, McNamara P, Nasoff M, DiDonato M, Glynne R, Herman AE.

PLoS One. 2013 Oct 24;8(10):e78483. doi: 10.1371/journal.pone.0078483. eCollection 2013.

20.

Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β.

Hübner MP, Shi Y, Torrero MN, Mueller E, Larson D, Soloviova K, Gondorf F, Hoerauf A, Killoran KE, Stocker JT, Davies SJ, Tarbell KV, Mitre E.

J Immunol. 2012 Jan 15;188(2):559-68. doi: 10.4049/jimmunol.1100335. Epub 2011 Dec 14.

Supplemental Content

Support Center